Immunization with influenza virus hemagglutinin globular region containing the receptor-binding pocket

Viral Immunology

Volumn 15, Issue 1, 2002, Pages 165-176

  Jeon, Sung Ho ^a   Arnon, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; INFLUENZA VIRUS HEMAGGLUTININ; MEMBRANE PROTEIN; OLIGOSACCHARIDE; PLASMID DNA; RECEPTOR; VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA VIRUS; LUNG HOMOGENATE; MOUSE; NONHUMAN; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TH1 CELL; VIRUS PARTICLE;

ANIMALIA; INFLUENZA VIRUS; RNA VIRUSES;

EID: 0036203656     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282402317340314     Document Type: Article

References (39)

1. The immune response to influenza infection
2. Synthetic peptide based vaccines as vaccines
3. Synthetic recombinant vaccine induce anti-influenza long-term immunity and cross strain protection
4. Growth purification and titration influenza viruses
5. Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
6. Type I IFN modulates innate and specific antiviral immunity
7. + T cell help
8. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine
9. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses
10. Influenza- specific antibody-secreting cells and B cell memory in the murine lung after immunization with wild-type, cold-adapted variant and inactivated influenza viruses
11. The epidemiology of influenza
12. Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin
13. Antigenic drift in type A influenza virus sequence differences in the haemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies
14. Amino acids sequence changes in the haemagglutinin of A/Hong Kong (H3N2) influenza virus during the period 1968-77
15. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
16. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection
17. 2 response of peripheral blood lymphocytes and increase of both serum and secretory anti-pneumococcal antibodies
18. Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice
19. Enzymatic characterization of interferon-induced antiviral GTPases murine Mx1 and human MxA proteins
20. Anti-influenza response achieved by immunization with a synthetic conjugate
21. Combined oral/nasal immunization protects mice from Sendai virus infection
22. Inactivated influenza virus vaccine, pp
23. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
24. Passive transfer of local immunity to influenza virus infection by IgA antibody
25. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type I Env antibody elicited by DNA priming and protein boosting
26. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia
27. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
28. A synthetic vaccine against influenza with built-in adjuvanticity
29. Receptor binding and membrane fusion in virus entry The influenza hemagglutinin
30. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice
31. Interferon-induced proteins and the antiviral state
32. Heterologous protection against influenza by injection of DNA encoding a viral protein
33. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines
34. Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms
35. Molecular mechanism of variation in influenza viruses
36. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
37. Structural basis of immune recognition of influenza virus haemagglutinin
38. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
39. Cytotoxic T-cells to type A influenza virus; viral haemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity